APA

Linch M., Gennatas S., Kazikin S., Iqbal J., Gunapala R., Priest K., Severn J., Norton A., Ayite B., Bhosle J., O'Brien M. & Popat S. (20150528). A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice. : BMC cancer.

Chicago

Linch Mark, Gennatas Spyridon, Kazikin Stanislav, Iqbal Jhangir, Gunapala Ranga, Priest Kathryn, Severn Joanne, Norton Alison, Ayite Bee, Bhosle Jaishree, O'Brien Mary and Popat Sanjay. 20150528. A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice. : BMC cancer.

Harvard

Linch M., Gennatas S., Kazikin S., Iqbal J., Gunapala R., Priest K., Severn J., Norton A., Ayite B., Bhosle J., O'Brien M. and Popat S. (20150528). A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice. : BMC cancer.

MLA

Linch Mark, Gennatas Spyridon, Kazikin Stanislav, Iqbal Jhangir, Gunapala Ranga, Priest Kathryn, Severn Joanne, Norton Alison, Ayite Bee, Bhosle Jaishree, O'Brien Mary and Popat Sanjay. A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice. : BMC cancer. 20150528.